The FDA announced 510(k) clearance for Inari Medical’s FlowTriever device for the treatment of pulmonary embolism (“PE”). According to Inari, the FlowTriever system is the first thrombectomy device ...

Powerfully simple thrombectomy solution provides physicians with an all-in-one, single-use aspiration catheter and pump system Intuitive design eliminates the need for capital equipment, with easy ...

Surmodics, Inc. SRDX recently announced the successful early clinical use of the company’s Pounce LP (Low Profile) Thrombectomy System. With the addition of a low-profile device, the Surmodics Pounce ...

The mechanical thrombectomy devices market is expected to grow at a steady rate during the forecast period. These devices are the gold standard for the treatment of blood clot and revascularization, ...

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and effectiveness results were ...

Please provide your email address to receive an email when new articles are posted on . Two new thrombectomy devices showed good safety and efficacy in the treatment of intermediate-risk pulmonary ...

Long Beach, Calif. – May 3, 2024 – Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The ...

NEW ORLEANS -- Large-bore mechanical thrombectomy for high-risk pulmonary embolism (PE) was associated with fewer major adverse outcomes than other approaches, the FLAME study showed. Clot removal ...

BOSTON, MA—A percutaneous mechanical thrombectomy device for pulmonary embolism (PE) improves hemodynamics and heart rate while patients are still in the procedure room, according to outcomes from the ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the mechanical thrombectomy devices market and it is poised to grow by USD 246.15 million during 2020-2024, progressing at a CAGR of almost 7% ...

Devicemaker Surmodics aims to broaden its clot-removal portfolio from arteries into veins with the acquisition of an Irish developer and its catheter built for relieving venous thromboembolisms. Vetex ...

Boston Scientific Corp. grabbed the remaining shares of Devoro Medical Inc. and its Wolf thrombectomy platform in a transaction valued at $269 million. Freemont, Calif.-based Devoro stands to gain an ...